Thousands to watch rare total eclipse in Australia

Updated 12 November 2012
0

Thousands to watch rare total eclipse in Australia

SYDNEY: Tens of thousands of people were flocking to Australia’s tropical north Monday to watch a rare total solar eclipse, a phenomenon officials say has not been seen in the region in 1,300 years.
The Queensland state government expects up to 60,000 visitors will witness on Wednesday the alignment of the sun, moon and earth which creates one of the most spectacular sights in nature, essentially turning day into night.
Northern Australia is the only place where crowds will be able to view the eclipse, which will mainly take place over the vast South Pacific.
“This one is a bit unique because we are not going to have another eclipse in Australia for years,” said Journeys Worldwide managing director Dick Cijffers, who runs specialist eclipse tours.
The eclipse starts at sunrise in the Northern Territory east of Darwin and passes across Australia’s top eastern cape before heading out over the South Pacific toward the north of New Zealand.
From sunrise on Wednesday (2035 GMT Tuesday) the moon will begin to cross in front of the sun, gradually passing over it until it is completely covered, bringing with it a shadow path.
The whole process will take several hours, with the skies in the path gradually darkening and lightening again, but the maximum duration for the total eclipse on the Australian mainland will be two minutes and five seconds.
The best place to view the eclipse will be between Cairns and Port Douglas, tourism hotspots close to the Great Barrier Reef and the Daintree rain forest.
Tourism operators say everything from camping grounds to five-star hotels have been booked up, with other eclipse watchers set to view the event from hot air balloons or boats moored on the center line of the eclipse.
“Cairns is pretty much full, it’s hard to find accommodation at the moment,” said a spokesman for Tourism Tropical North Queensland, adding that there had been keen interest from the United States, Japan and Germany.
For those positioned outside a roughly 150-kilometer (95-mile)-wide central path but who are still partly in the moon’s shadow, the eclipse is partial — it will look as though a bite has been taken out of the sun.
A partial eclipse will be visible in Papua New Guinea, the extreme eastern part of Indonesia, eastern Australia, New Zealand, Polynesia, part of Antarctica and the southern part of Chile and Argentina.


Saudi Society for Medical Genetics approves 12 recommendations to combat diseases

Updated 21 May 2018
0

Saudi Society for Medical Genetics approves 12 recommendations to combat diseases

  • More than 130 pediatricians, geneticists, genetic researchers, laboratory technicians, nutritionists attended the conference from across the kingdom.
  • The conference is an opportunity for medical professionals and workers in the region to keep up-to-date with the most important developments.

RIYADH: Saudi Society of Medical Genetics (SSMG) concluded its conference in Riyadh by approving 12 recommendations aimed at fighting genetic diseases, the Saudi Press Agency reported Monday.

More than 130 pediatricians, geneticists, genetic researchers, laboratory technicians, nutritionists attended the conference from across the kingdom.

President of the Association, Dr. Zuhair Rahbini, praised the success of the conference, saying it comes in line with the efforts of Saudi government to support all that serves the citizen and supports social health efforts and increases awareness levels to confront genetic diseases.

Dr. Saleh bin Mohammed Al-Ghamdi, Chairman of the Genetic Research Committee, said the conference has come out with 12 recommendations related to many topics covered by the conference, which include genes, the human genome and the relationship of genes to other environmental factors.

The conference is an opportunity for medical professionals and workers in the country to keep up-to-date with the most important developments, such as early screening for metabolic diseases in newborns, their clinical treatment and new medical treatments across the spectra of metabolic diseases.